Tiziana Life Sciences Ltd (TLSA) director adds 15,000 shares in open-market buy
Rhea-AI Filing Summary
Tiziana Life Sciences Ltd director and ten percent owner Gabriele M. Cerrone, through Panetta Partners Limited, purchased 15,000 shares of common stock in an open-market transaction at $1.11 per share on June 12, 2026, bringing indirect holdings to 44,772,230 shares. This amended report updates only the transaction code associated with that purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 15,000 shares
Net Buy
1 txn
Insider
CERRONE GABRIELE M
Role
Director, 10% Owner
Bought
15,000 shs ($17K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | COMMON STOCK | 15,000 | $1.11 | $17K |
Holdings After Transaction:
COMMON STOCK — 44,772,230 shares (Indirect, Via Panetta Partners Limited)
Key Figures
Shares purchased: 15,000 shares
Purchase price: $1.1100 per share
Indirect holdings after trade: 44,772,230 shares
+1 more
4 metrics
Shares purchased
15,000 shares
Open-market purchase of common stock on June 12, 2026
Purchase price
$1.1100 per share
Price for the 15,000-share common stock purchase
Indirect holdings after trade
44,772,230 shares
Total TLSA common shares held indirectly via Panetta Partners Limited after the transaction
Net buy shares
15,000 shares
Net share change across all reported non-derivative transactions in this filing
Key Terms
open market purchase, indirect ownership, ten percent owner, non-derivative
4 terms
open market purchase financial
"transaction_code_description: "Purchase in open market or private transaction""
An open market purchase is when a company buys its own shares on public stock exchanges the same way any investor would, rather than through a private deal. Investors care because these purchases reduce the number of shares available, can boost earnings per share and share price, signal that management thinks the stock is undervalued, and use company cash that might otherwise go to reinvestment or dividends — like a business quietly buying back its own tickets at the box office.
indirect ownership financial
"ownership_type: "indirect" with nature_of_ownership "Via Panetta Partners Limited""
ten percent owner financial
""is_ten_percent_owner": 1 for reporting person Gabriele M. Cerrone"
non-derivative financial
"transaction_type set to "non-derivative" for the common stock purchase"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did TLSA report in this Form 4/A amendment?
Tiziana Life Sciences Ltd reported that 15,000 common shares were purchased in an open-market transaction at $1.11 per share. The trade was made indirectly through Panetta Partners Limited.
Who is the TLSA insider in this Form 4/A and what is their role?
The reporting person is Gabriele M. Cerrone, a director and ten percent owner of Tiziana Life Sciences Ltd. The purchase was made indirectly through Panetta Partners Limited on his behalf.
What change does this Form 4/A make to the earlier TLSA filing?
The amendment states it only corrects the transaction code linked to this open-market purchase. It confirms that no other reported transactions or economic details are affected by the correction.
Was the TLSA insider trade reported as part of a Rule 10b5-1 plan?
The filing’s Rule 10b5-1 checkbox is not marked, so it does not state that the trade was made under a pre-arranged trading plan. No separate footnote describes it as a 10b5-1 transaction.